“…In fact, the fractions of early lesions in such tissues will probably show higher frequency of DDR barrier activation than in the corresponding malignant lesions, similar to the data based on different stages of progression among human lung, bladder and colon tumours, for example (Gorgoulis et 2007). Second, cell culture and mouse model experiments in numerous laboratories demonstrated that activated oncogenes evoke a robust DDR activation in diverse cell types, including primary fibroblasts, lymphocytes and epithelial cells (Powers et al, 2004;Gorgoulis et al, 2005;Bartkova et al, 2005aBartkova et al, , 2006Di Micco et al, 2006;Frame et al, 2006;Pusapati et al, 2006;Reimann et al, 2007;.…”